BAX gene (−248 G > A) polymorphism in a sample of patients diagnosed with thyroid cancer in the Federal District, Brazil

1. Pan, D, Wen, D, Luo, Y, et al. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases. Onco Targets Ther 2017; 10: 3261.
Google Scholar | Crossref | Medline2. Steck, JH . Validade do mapeamento do linfonodo sentinela na detecção de metástase linfática cervical do carcinoma papilífero da glândula tireoide. PhD Thesis, Universidade de São Paulo, São Paulo - SP, Brazil, 2016.
Google Scholar | Crossref3. Heidari, Z, Eskandari, M, Aryan, A, et al. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma. Br J Biomed Sci 2020; 77: 129–134.
Google Scholar | Medline4. INCA . Estimativa 2020 Incidência de Câncer no Brasil. Brasil: Rio de Janeiro, 2019, p. 44–45.
Google Scholar5. Uhliarova, B, Hajtman, A. Hashimoto's thyroiditis-an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol 2018; 84: 729–735.
Google Scholar | Crossref | Medline6. Sun, L, Wei, L, Wei, L, et al. Correlation between Bax gene polymorphisms and esophagus cancer. Oncol Lett 2018; 16: 7097–7101.
Google Scholar | Medline7. Spanu, A, Solinas, ME, Chessa, F, et al. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med 2009; 50: 184–190.
Google Scholar | Crossref | Medline8. Spanu, A, Nuvoli, S, Gelo, I, et al. Role of diagnostic 131I SPECT/CT in long-term follow-up of patients with papillary thyroid microcarcinoma. J Nucl Med 2018; 59: 1510–1515.
Google Scholar | Crossref | Medline9. Spanu, A, Nuvoli, S, Marongiu, A, et al. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. BMC Cancer 2020; 20: 1–10.
Google Scholar | Crossref10. Haugen, BR, Alexander, EK, Bible, KC, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2015; 2016; 26:1–133.
Google Scholar11. Romero-Sánchez, C, Gómez-Gutierrez, A, Gómez, PE, et al. C677t (rs1801133) MTFHR gene polymorphism frequency in a Colombian population. Colomb Med 2015; 46: 75–79.
Google Scholar | Crossref12. Dholariya, S, Mir, R, Zuberi, M, et al. Potential impact of (rs 4645878) BAX promoter − 248G> A and (rs 1042522) TP53 72Arg> pro polymorphisms on epithelial ovarian cancer patients. Clin Transl Oncol 2016; 18: 73–81.
Google Scholar | Crossref | Medline13. Mirmajidi, SH, Najafi, M, Mirmajidi, ST, et al. Study of regulatory promoter polymorphism (−248 G > A) of Bax gene in patients with gastric cancer in the northern provinces of Iran. Gastroenterol Hepatol Bed Bench 2016; 9: 36.
Google Scholar | Medline14. Gonçalves, RP, Bonani, FA, Santos, RV, et al. Fatores de risco para carcinoma bem diferenciado de tireoide: análise crítica de 463 casos. Rev Brás Cir Cabeça Pescoço 2012; 41: 23–26.
Google Scholar15. Mayrhofer, BF, Santos, C, Cristine, G, et al. Utilização dos hormônios calcitonina, catecolaminas E tireoglobulina como marcadores tumorais: uma revisão bibliográfica. Saúde e Desenvolv 2019; 11: 60–69.
Google Scholar16. Fighera, TM, Perez, CLS, Faris, N, et al. TSH Levels are associated with increased risk of thyroid carcinoma in patients with nodular disease. Endokrynol Pol 2015; 66: 480–485.
Google Scholar | Crossref | Medline17. Bueno, F, Falcone, MGG, Peñaloza, MA, et al. Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer. Endocrine 2020; 67: 387–396.
Google Scholar | Crossref | Medline18. Bilous, I, Pavlovych, L, Krynytska, I, et al. Apoptosis and cell cycle pathway-focused genes expression analysis in patients with different forms of thyroid pathology. Open Access Maced J Med Sci 2020; 8: 784–792.
Google Scholar | Crossref19. Kelly, A, Barres, B, Kwiatkowski, F, et al. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients. PLoS One 2019; 14: e0221298.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif